Yeongshin Kim

Songnam, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis.

A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis.

Journal: Frontiers in immunology

Published: February 13, 2025

Association Between Childhood Trauma and Anhedonia-Related Symptoms: The Mediation Role of Trait Anhedonia and Circulating Proteins.

Association Between Childhood Trauma and Anhedonia-Related Symptoms: The Mediation Role of Trait Anhedonia and Circulating Proteins.

Journal: Journal of Korean medical science

Published: July 20, 2024

TAT38 and TAT38 mimics potently inhibit adipogenesis by repressing C/EBPα, PPARγ, Pi-PPARγ, and SREBP1 expression.

TAT38 and TAT38 mimics potently inhibit adipogenesis by repressing C/EBPα, PPARγ, Pi-PPARγ, and SREBP1 expression.

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms

Published: February 01, 2024

High-throughput proteomics-guided biomarker discovery of hepatocellular carcinoma.

High-throughput proteomics-guided biomarker discovery of hepatocellular carcinoma.

Journal: Biomedical journal

Published: January 28, 2024

Multiplexed Quantitative Proteomics Reveals Proteomic Alterations in Two Rodent Traumatic Brain Injury Models.

Multiplexed Quantitative Proteomics Reveals Proteomic Alterations in Two Rodent Traumatic Brain Injury Models.

Journal: Journal of proteome research

Published: December 08, 2023

Evaluation of a Nondepleted Plasma Multiprotein-Based Model for Discriminating Psychiatric Disorders Using Multiple Reaction Monitoring-Mass Spectrometry: Proof-of-Concept Study.

Evaluation of a Nondepleted Plasma Multiprotein-Based Model for Discriminating Psychiatric Disorders Using Multiple Reaction Monitoring-Mass Spectrometry: Proof-of-Concept Study.

Journal: Journal of proteome research

Published: December 08, 2023

Network analysis of plasma proteomes in affective disorders.

Network analysis of plasma proteomes in affective disorders.

Journal: Translational psychiatry

Published: January 13, 2023

Latent class analysis of psychotic-affective disorders with data-driven plasma proteomics.

Latent class analysis of psychotic-affective disorders with data-driven plasma proteomics.

Journal: Translational psychiatry

Published: August 22, 2022

Comparison of Fucose-Specific Lectins to Improve Quantitative AFP-L3 Assay for Diagnosing Hepatocellular Carcinoma Using Mass Spectrometry.

Comparison of Fucose-Specific Lectins to Improve Quantitative AFP-L3 Assay for Diagnosing Hepatocellular Carcinoma Using Mass Spectrometry.

Journal: Journal of proteome research

Published: May 10, 2022

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia.

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia.

Journal: Clinical and translational medicine

Published: March 23, 2022

Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry.

Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry.

Journal: Scientific reports

Published: March 05, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026